Hanna Dêbiec

9.9k total citations · 2 hit papers
117 papers, 5.4k citations indexed

About

Hanna Dêbiec is a scholar working on Nephrology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Hanna Dêbiec has authored 117 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Nephrology, 36 papers in Pathology and Forensic Medicine and 31 papers in Molecular Biology. Recurrent topics in Hanna Dêbiec's work include Renal Diseases and Glomerulopathies (87 papers), Autoimmune Bullous Skin Diseases (29 papers) and Vasculitis and related conditions (23 papers). Hanna Dêbiec is often cited by papers focused on Renal Diseases and Glomerulopathies (87 papers), Autoimmune Bullous Skin Diseases (29 papers) and Vasculitis and related conditions (23 papers). Hanna Dêbiec collaborates with scholars based in France, United States and Italy. Hanna Dêbiec's co-authors include Pierre Ronco, Sanjeev Sethi, Fernando C. Fervenza, Vincent Guigonis, Jack F.M. Wetzels, Georges Deschênes, M. Cristine Charlesworth, Karine Dahan, LouAnn Gross and Aishwarya Ravindran and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Hanna Dêbiec

114 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

2016 281 citations Karine Dahan, Hanna Dêbiec et al. Journal of the American Society of Nephrology profile →
Membranous nephropathy

2021 248 citations Pierre Ronco, Laurence H. Beck et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanna Dêbiec France	36	4.6k	1.9k	1.8k	1.1k	875	117	5.4k
Vera Eremina Canada	23	2.4k 0.5×	808 0.4×	310 0.2×	2.3k 2.0×	631 0.7×	25	4.9k
Constantinos Deltas Cyprus	31	1.1k 0.2×	375 0.2×	531 0.3×	2.4k 2.1×	434 0.5×	104	4.3k
Karin Dahan Belgium	26	1.6k 0.4×	519 0.3×	433 0.2×	1.6k 1.4×	195 0.2×	71	3.2k
Hiroshi Kaito Japan	27	1.1k 0.2×	307 0.2×	353 0.2×	939 0.8×	187 0.2×	110	2.3k
Karine Dahan France	22	993 0.2×	582 0.3×	392 0.2×	484 0.4×	273 0.3×	50	2.5k
Julie A. Vrana United States	34	974 0.2×	288 0.2×	194 0.1×	2.6k 2.2×	395 0.5×	69	3.6k
Tetsuya Kawamura Japan	25	974 0.2×	309 0.2×	234 0.1×	1.1k 0.9×	318 0.4×	131	2.6k
Isao Shirato Japan	29	1.6k 0.3×	203 0.1×	260 0.1×	833 0.7×	454 0.5×	101	2.8k
Chengsen Xue United States	9	860 0.2×	803 0.4×	208 0.1×	1.9k 1.7×	365 0.4×	13	3.7k
Janet A. Gilbertson United Kingdom	31	1.6k 0.4×	336 0.2×	152 0.1×	3.9k 3.4×	114 0.1×	96	4.7k

Countries citing papers authored by Hanna Dêbiec

Since Specialization

Citations

This map shows the geographic impact of Hanna Dêbiec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Dêbiec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Dêbiec more than expected).

Fields of papers citing papers by Hanna Dêbiec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Dêbiec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Dêbiec. The network helps show where Hanna Dêbiec may publish in the future.

Co-authorship network of co-authors of Hanna Dêbiec

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Dêbiec. A scholar is included among the top collaborators of Hanna Dêbiec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Dêbiec. Hanna Dêbiec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berge, Bartholomeus T. van den, Martijn van den Broek, Hanna Dêbiec, et al.. (2025). Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome. Nephrology Dialysis Transplantation. 40(9). 1736–1745.

Barbour, Sean J., Manuel Praga, Fernando Caravaca‐Fontán, et al.. (2025). Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy. Clinical Journal of the American Society of Nephrology. 20(6). 854–865. 2 indexed citations

Habbig, Sandra, Hanna Dêbiec, Dirk L. Stippel, et al.. (2025). Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis. Kidney International. 108(2). 321–327.

Sethi, Sanjeev, Benjamin J. Madden, Marta Casal Moura, et al.. (2024). FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection. Kidney International. 106(5). 985–990. 7 indexed citations

Eikrem, Øystein, Nicolas Delaleu, Tarig Osman, et al.. (2023). Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target. Biomedicines. 11(1). 226–226. 4 indexed citations

Zhang, Xiaodan, Zhao Cui, Lei Liu, et al.. (2022). Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy. Kidney International. 103(3). 580–592. 8 indexed citations

Sethi, Sanjeev, Benjamin J. Madden, Hanna Dêbiec, et al.. (2021). Protocadherin 7–Associated Membranous Nephropathy. Journal of the American Society of Nephrology. 32(5). 1249–1261. 98 indexed citations

Yousfi, Nadhir, et al.. (2021). Modélisation de la barrière de filtration glomérulaire. Springer Link (Chiba Institute of Technology). 1 indexed citations

Ronco, Pierre, Laurence H. Beck, Hanna Dêbiec, et al.. (2021). Membranous nephropathy. Nature Reviews Disease Primers. 7(1). 69–69. 248 indexed citations breakdown →

10.

Santoro, Domenico, Hanna Dêbiec, Massimo Torreggiani, et al.. (2021). Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report. American Journal of Kidney Diseases. 80(2). 289–294. 13 indexed citations

11.

Sethi, Sanjeev, Benjamin J. Madden, Vivian Negron, et al.. (2020). Protocadherin 7-Associated Membranous Nephropathy. Journal of the American Society of Nephrology. 31(10S). 26–26. 3 indexed citations

12.

Sethi, Sanjeev, Benjamin Madden, Hanna Dêbiec, et al.. (2019). Exostosin 1/Exostosin 2–Associated Membranous Nephropathy. Journal of the American Society of Nephrology. 30(6). 1123–1136. 196 indexed citations

13.

Wang, Huaiyu, Zhao Cui, Lijie Zhang, et al.. (2018). HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy. Kidney International. 94(5). 974–982. 19 indexed citations

14.

Vivarelli, Marina, Francesco Emma, Stefania Pedicelli, et al.. (2015). Genetic homogeneity but IgG subclass–dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies. Kidney International. 87(3). 602–609. 34 indexed citations

15.

Ronco, Pierre & Hanna Dêbiec. (2012). Pathogenesis of membranous nephropathy: recent advances and future challenges. Nature Reviews Nephrology. 8(4). 203–213. 125 indexed citations

16.

Michel, P.A., Karine Dahan, Pierre‐Yves Ancel, et al.. (2011). Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients. PubMed. 1(1). 251–261. 19 indexed citations

17.

Dêbiec, Hanna, Laurent Martin, Chantal Jouanneau, et al.. (2011). Autoantibodies Specific for the Phospholipase A2 Receptor in Recurrent and De Novo Membranous Nephropathy. American Journal of Transplantation. 11(10). 2144–2152. 103 indexed citations

18.

Seigneux, Sophie de, Pascal Bindi, Hanna Dêbiec, et al.. (2010). Immunoglobulin Deposition Disease With a Membranous Pattern and a Circulating Monoclonal Immunoglobulin G With Charge-Dependent Aggregation Properties. American Journal of Kidney Diseases. 56(1). 117–121. 20 indexed citations

19.

Dêbiec, Hanna. (2002). Abnormal renal phenotype in L1 knockout mice: a novel cause of CAKUT. Nephrology Dialysis Transplantation. 17(90009). 42–44. 28 indexed citations

20.

Dêbiec, Hanna, et al.. (1990). Mechanism and regulation of intestinal phosphate absorption.. PubMed. 16(2-3). 115–24. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact